Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000825315 | SCV000966610 | uncertain significance | not specified | 2018-03-02 | criteria provided, single submitter | clinical testing | The p.Phe190Ile variant in COL4A3 has not been previously reported in individual s with Alport syndrome, but has been identified in 3/33550 Latino chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSN P rs371173786). Although this variant has been seen in the general population, i ts frequency is not high enough to rule out a pathogenic role. Computational pre diction tools and conservation analyses do not provide strong support for or aga inst an impact to the protein. In summary, the clinical significance of the p.Ph e190Ile variant is uncertain. ACMG/AMP Criteria applied: PM2. |
Natera, |
RCV001825679 | SCV002076384 | uncertain significance | Alport syndrome | 2020-09-09 | no assertion criteria provided | clinical testing |